United Therapeutics Corporation (UTHR)
$352.39
United Therapeutics Corporation (UTHR) Share Price Forecast
Currently 22 wall-street analysts regularly analyze the financials of United Therapeutics Corporation on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for United Therapeutics Corporation (UTHR) have a share price target of $367.52. This median of share price forecast represents a 4.29% upside from the latest price of $352.39 as on 08.10.24.
United Therapeutics Corporation (UTHR) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the United Therapeutics Corporation (UTHR) share price will touch around $367.52 in next 12-months.
United Therapeutics Corporation (UTHR) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between United Therapeutics Corporation's share price and its median forecast price. As on 08.10.24, the difference is -2.64%
United Therapeutics Corporation (UTHR): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
United Therapeutics Corporation (UTHR) Share Price : Analyst Recommendation
Based on 22 analysts tracking and researching United Therapeutics Corporation (UTHR) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 9 | 10 | 10 |
| Outperform | 8 | 8 | 8 |
| Hold | 2 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 2 | 1 | 1 |
United Therapeutics Corporation (UTHR) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for United Therapeutics Corporation (UTHR) is $367.52, offered by 22 analysts offering 12-month price forecasts.
United Therapeutics Corporation (UTHR) has a maximum of 0.04 upside potential, based on 22 analysts offering 12-month price forecasts.
Based on 22 analysts tracking and researching United Therapeutics Corporation (UTHR), 81.82% have a buy recommendation. Remaining 18.18% have either sell or hold recommendations.
The latest share price of United Therapeutics Corporation (UTHR) is $352.39 as of 08/10/2024.
18 of total 22 analysts offering stock ratings for United Therapeutics Corporation UTHR have recommended buy rating.
₹0 US Stocks a/c Opening Fee